Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy

被引:31
|
作者
Häussinger, D [1 ]
Görg, B [1 ]
Reinehr, R [1 ]
Schliess, F [1 ]
机构
[1] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany
关键词
oxidative stress; nitric oxide; liver; astrocytes; INDUCED BRAIN EDEMA; MAGNETIC-RESONANCE SPECTROSCOPY; REGULATORY VOLUME DECREASE; ACUTE AMMONIA INTOXICATION; LONG-LASTING ENHANCEMENT; CULTURED RAT ASTROCYTES; NITRIC-OXIDE SYNTHASE; D-ASPARTATE RECEPTORS; AMINO-ACID RELEASE; PORTACAVAL ANASTOMOSIS;
D O I
10.1007/s11011-005-7908-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatic encephalopathy is seen as a clinical manifestation of a chronic low grade cerebral edema, which is thought to trigger disturbances of astrocyte function, glioneuronal communication, and finally HE symptoms. In cultured astrocytes, hypoosmotic swelling triggers a rapid oxidative stress response, which involves the action of NADPH oxidase isoenzymes, followed by tyrosine nitration of distinct astrocytic proteins. Oxidative stress and protein tyrosine nitration (PTN) are also observed in response to ammonia, inflammatory cytokines, such as TNF-alpha or interferons, and benzodiazepines with affinity to the peripheral benzodiazepine receptor (PBR). NMDA receptor activation was identified as upstream event in protein tyrosine nitration (PTN). Cerebral PTN is also found in vivoafter administration of ammonia, benzodiazepines or lipopolysaccharide and in portocaval shunted rats. PTN predominantly affects astrocytes surrounding cerebral vessels with potential impact on blood-brain-barrier permeability. Among the tyrosine-nitrated proteins, glutamine synthetase, GAPDH, extracellular signal-regulated kinase and the PBR were identified. PTN of glutamine synthetase is associated with inactivation of the enzyme. Thus, factors known to trigger hepatic encephalopathy induce oxidative/nitrosative stress on astrocytes with protein modifications through PTN. The pathobiochemical relevance of astrocytic PTN for the development of HE symptoms remains to be established.
引用
收藏
页码:285 / 294
页数:10
相关论文
共 50 条
  • [1] Protein Tyrosine Nitration in Hyperammonemia and Hepatic Encephalopathy
    Dieter Häussinger
    Boris Görg
    Roland Reinehr
    Freimut Schliess
    Metabolic Brain Disease, 2005, 20 : 285 - 294
  • [2] Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy
    Häussinger, D
    Schliess, F
    NEUROCHEMISTRY INTERNATIONAL, 2005, 47 (1-2) : 64 - 70
  • [3] Hyperammonemia in Hepatic Encephalopathy
    Jayakumar, A. R.
    Norenberg, Michael D.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (03) : 272 - 280
  • [4] HYPERAMMONEMIA AND HEPATIC ENCEPHALOPATHY IN DOG
    STROMBECK, DR
    WEISER, MG
    KANEKO, JJ
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1975, 166 (11) : 1105 - 1108
  • [5] Elevated dopamine induces minimal hepatic encephalopathy by activation of astrocytic NADPH oxidase and astrocytic protein tyrosine nitration
    Ding, Saidan
    Yang, Jianjing
    Liu, Leping
    Ye, Yiru
    Wang, Xuebao
    Hu, Jiangnan
    Chen, Bicheng
    Zhuge, Qichuan
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 55 : 252 - 263
  • [6] NMDA receptors in hyperammonemia and hepatic encephalopathy
    Llansola, Marta
    Rodrigo, Regina
    Monfort, Pilar
    Montoliu, Carmina
    Kosenko, Elena
    Cauli, Omar
    Piedrafita, Blanca
    El Mlili, Nisrin
    Felipo, Vicente
    METABOLIC BRAIN DISEASE, 2007, 22 (3-4) : 321 - 335
  • [8] NMDA receptors in hyperammonemia and hepatic encephalopathy
    Marta Llansola
    Regina Rodrigo
    Pilar Monfort
    Carmina Montoliu
    Elena Kosenko
    Omar Cauli
    Blanca Piedrafita
    Nisrin El Mlili
    Vicente Felipo
    Metabolic Brain Disease, 2007, 22 : 321 - 335
  • [9] Nitric oxide in hepatic encephalopathy and hyperammonemia
    Rao, VLR
    NEUROCHEMISTRY INTERNATIONAL, 2002, 41 (2-3) : 161 - 170
  • [10] HYPERAMMONEMIA AND HEPATIC ENCEPHALOPATHY IN CIRRHOTICS TREATED WITH SPIRONOLACTONE
    IMLER, M
    SCHLIENGER, JL
    NOUVELLE PRESSE MEDICALE, 1977, 6 (37): : 3407 - 3410